{"id":1141,"date":"2026-08-03T08:14:20","date_gmt":"2026-08-03T11:14:20","guid":{"rendered":"https:\/\/www.vitapharmaconsulting.com\/en\/?post_type=noticias&p=1141"},"modified":"2026-08-03T08:15:15","modified_gmt":"2026-08-03T11:15:15","slug":"anvisa-updates-the-active-ingredient-registration","status":"publish","type":"noticias","link":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/","title":{"rendered":"ANVISA updates the Active Ingredient Registration Panel (Painel de Princ\u00edpios Ativos em Registro): expanded data, greater depth for regulatory intelligence"},"content":{"rendered":"

In its original format, the panel displayed three variables per entry: active ingredient, regulatory category, and number of pending processes. The updated version introduces two additional dimensions: pharmaceutical form and concentration. The interface has also been redesigned for improved usability.<\/span><\/p>\n

The practical implications for companies operating in the Brazilian market are substantial. The panel now enables:<\/span><\/p>\n

    \n
  1. more granular identification of submitted formulations \u2014 distinguishing, for example, between different dosage forms or strength ranges of the same active ingredient;<\/span><\/li>\n
  2. deeper assessment of competitive density by product profile, rather than by active ingredient alone;<\/span><\/li>\n
  3. more informed decisions on prioritization requests, based on the actual volume and profile of pending submissions for a given molecule and form; and<\/span><\/li>\n
  4. validation or recalibration of submission strategies for products in prospecting or development.<\/span><\/li>\n<\/ol>\n

    The panel covers all registration categories: new medicines, generics, similars, specific medicines, herbal medicines, biologics, biosimilars, radiopharmaceuticals, and advanced therapy products. Clone medicines (RDC No.\u00a0954\/2024) are not included.<\/span><\/p>\n

    Those classified as Innovators are grouped in the New Medicines category.<\/span><\/p>\n

    No official notice has been published by ANVISA regarding this update. The changes are accessible directly through the panel.<\/span><\/p>\n

    Access the panel<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":1142,"template":"","meta":{"inline_featured_image":false,"_links_to":"","_links_to_target":""},"categorias":[22],"yoast_head":"\nANVISA updates the Active Ingredient Registration Panel<\/title>\n<meta name=\"description\" content=\"In its original format, the panel displayed three variables per entry: active ingredient, regulatory category, and number of pending processes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANVISA updates the Active Ingredient Registration Panel\" \/>\n<meta property=\"og:description\" content=\"In its original format, the panel displayed three variables per entry: active ingredient, regulatory category, and number of pending processes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/\" \/>\n<meta property=\"og:site_name\" content=\"Vita\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-03T11:15:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/08\/ANVISA-updates-the-Active-Ingredient-Registration-Panel.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1800\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/\",\"name\":\"ANVISA updates the Active Ingredient Registration Panel\",\"isPartOf\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\"},\"datePublished\":\"2026-08-03T11:14:20+00:00\",\"dateModified\":\"2026-08-03T11:15:15+00:00\",\"description\":\"In its original format, the panel displayed three variables per entry: active ingredient, regulatory category, and number of pending processes.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Not\u00edcias\",\"item\":\"https:\/\/www.vitapharmaconsulting.com\/en\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANVISA updates the Active Ingredient Registration Panel (Painel de Princ\u00edpios Ativos em Registro): expanded data, greater depth for regulatory intelligence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.vitapharmaconsulting.com\/en\/#website\",\"url\":\"https:\/\/www.vitapharmaconsulting.com\/en\/\",\"name\":\"Vita\",\"description\":\"Regulatory affairs & consulting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANVISA updates the Active Ingredient Registration Panel","description":"In its original format, the panel displayed three variables per entry: active ingredient, regulatory category, and number of pending processes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/","og_locale":"pt_BR","og_type":"article","og_title":"ANVISA updates the Active Ingredient Registration Panel","og_description":"In its original format, the panel displayed three variables per entry: active ingredient, regulatory category, and number of pending processes.","og_url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/","og_site_name":"Vita","article_modified_time":"2026-08-03T11:15:15+00:00","og_image":[{"width":1800,"height":900,"url":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-content\/uploads\/2026\/08\/ANVISA-updates-the-Active-Ingredient-Registration-Panel.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/","url":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/","name":"ANVISA updates the Active Ingredient Registration Panel","isPartOf":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website"},"datePublished":"2026-08-03T11:14:20+00:00","dateModified":"2026-08-03T11:15:15+00:00","description":"In its original format, the panel displayed three variables per entry: active ingredient, regulatory category, and number of pending processes.","breadcrumb":{"@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/2026\/08\/03\/anvisa-updates-the-active-ingredient-registration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Not\u00edcias","item":"https:\/\/www.vitapharmaconsulting.com\/en\/news\/"},{"@type":"ListItem","position":2,"name":"ANVISA updates the Active Ingredient Registration Panel (Painel de Princ\u00edpios Ativos em Registro): expanded data, greater depth for regulatory intelligence"}]},{"@type":"WebSite","@id":"https:\/\/www.vitapharmaconsulting.com\/en\/#website","url":"https:\/\/www.vitapharmaconsulting.com\/en\/","name":"Vita","description":"Regulatory affairs & consulting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vitapharmaconsulting.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"}]}},"_links":{"self":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias\/1141"}],"collection":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/noticias"}],"about":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/types\/noticias"}],"author":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/users\/3"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media\/1142"}],"wp:attachment":[{"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=1141"}],"wp:term":[{"taxonomy":"categorias","embeddable":true,"href":"https:\/\/www.vitapharmaconsulting.com\/en\/wp-json\/wp\/v2\/categorias?post=1141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}